Overview

Major Depressive Disorder With Mixed Features

Status:
Withdrawn

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features.

Phase:

Phase 3

Details

Lead Sponsor:

Sunovion

Treatments:

Lurasidone Hydrochloride